Scientists have applied synthetic DNA technology to engineer a novel eCD4-Ig anti-HIV agent and to enhance its potency in vivo, providing a new simple strategy for constructing complex therapeutics for infectious agents as well as for diverse implications in therapeutic delivery.
from Top Health News -- ScienceDaily https://ift.tt/2LYFKe3
No comments:
Post a Comment